🔬 Medical Cyclotron Portfolio Overview

2026-02-02

Structured 7–20 MeV Platforms for Nuclear Medicine Applications

At Longevous Beamtech (LBT), we develop a structured medical cyclotron portfolio covering the 7–20 MeV energy range, designed to support different stages of nuclear medicine development — from routine clinical production to higher-capacity radiopharmaceutical manufacturing.

Rather than isolated models, each system is positioned for a clear application scenario, target configuration, and future scalability.

🔹 LB-7 Series (7 MeV class)

Designed for compact installations and routine clinical isotope production, the LB-7 platform is optimized for hospitals and nuclear medicine centers where space efficiency and operational simplicity are critical.

Typical application focus:

Routine PET radiopharmaceutical production
Compact facilities and hospital-based nuclear medicine departments
Liquid target configurations for daily clinical use

🔹 LB-11 Series (11 MeV class)

The LB-11 platform offers greater flexibility in isotope production, supporting a wider range of radionuclides and target options.

Key positioning:

Hospitals and regional production centers
Expanded isotope portfolios beyond routine tracers
Liquid and solid target compatibility, enabling higher yield and broader applications
A balanced solution between clinical routine and advanced production needs

🔹 LB-20 (20 MeV class)

The LB-20 is engineered for stable, continuous operation and higher production capacity, supporting both clinical supply and industrial-level radiopharmaceutical manufacturing.

Core characteristics:

High-capacity operation with long-term stability
Suitable for centralized or regional production centers
Multi-modal target support (gas, liquid, solid)
Designed for integration with downstream radiopharmaceutical processing workflows

Across the 7–20 MeV range, LBT emphasizes:

Platform-based cyclotron design
Consistent beam performance and operational reliability
Compatibility with integrated radiopharmaceutical production systems
Long-term scalability aligned with regulatory and clinical development paths

🌍 Building reliable nuclear medicine infrastructure — from hospital-based production to regional supply networks.